45 Under 45:The Change Generation
In our first ever Emerging Leadership Awards, we profile 45 talented young professionals who will lead pharma into the next generation
David Newman, GlaxoSmithKline
S
Blueprint for Excellence
In a time of slow growth, true innovators forge new relationships with core customers
Jeffrey Aronin, Ovation
Doctor's Orders
Dr. Michael Kessler and Mark Vitello of MD Mindset have the cure for the common sales pitch? Look at the transaction from the customer's perspective
Vlad Hogenhuis, Merck
Safi Bahcall, Synta Pharmaceuticals
Alan Tennenberg; Tibotec, J&J
Greg Parekh, Novartis
J. Martin Jernigan, Novo Nordisk
The Buddy System
Jean-Marc Niemetz on forming partnerships with the industry's major stakeholders
Blair Gibson, Merck
Julie McHugh, J&J
Being Bob: Q&A with Robert Essner
An industry legend weighs in on leadership, research, and sales models. Q&A with outgoing Wyeth Chairman Bob Essner
Rich Tillyer, Merck
Jared Silverman, Cubist
Ameet Mallik, Novartis
John Orwin, Genentech
Angela Moskow, Sanofi-Aventis
Stealth Pharmas
Second annual Not Big Pharma audit gives equal time to the little guys. Who's got the Midas touch?
Tariq Arshad, Pfizer
Suzanne Delaney, AstraZeneca
Susanne Schaffert, Novartis
Candidates Target Pharma
US presidential hopefuls look to comparative effectiveness analysis to address price and access issues
Evan Morris, Roche
Chris Claiborne, Millennium
Rob Perez, EVP and COO, Cubist Pharmaceuticals
John Shamsey, Bristol-Myers Squibb
